Acadia Pharmaceuticals

Director, Clinical Operations

Foster City, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Rare DiseasesIndustries

Requirements

Candidates should possess an advanced degree in a scientific or healthcare field and have over 10 years of experience in clinical research and organizational management within the pharmaceutical industry, with a preference for biotech or small pharma experience. Experience with global clinical trials is also required.

Responsibilities

The Director, Clinical Operations will provide leadership for assigned clinical programs, ensuring studies align with program goals, timelines, budgets, and quality expectations while adhering to FDA, GCP, and ICH regulations. Responsibilities include developing clinical trial management strategies, overseeing study execution, managing clinical operations teams, representing Clinical Operations at Product Teams, leading vendor selection and oversight, ensuring study consistency, providing input on trial design, authoring study documents, managing financial aspects, driving process improvements, and overseeing inspection readiness activities.

Skills

Clinical Trial Management
Budget Management
Resource Planning
GCP
ICH
FDA Regulations
Project Management
Leadership
Cross-functional Collaboration

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI